Company
Cardinal Health 414
Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
2
2 still marketed
Novel approvals
1
Approvals since 2021
1
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Lymphoseek Kit new use OrphanMay 19, 2021
- Lymphoseek Kit new use Oct 14, 2014
- Lymphoseek Kit new use Priority reviewJun 13, 2014
- Lymphoseek Kit approved NovelOrphanMar 13, 2013
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (2)
Newest FDA action first.
- Technetium Tc-99m Medronate Kit Technetium Tc-99m Medronate Kit · 1981
- Lymphoseek Kit Technetium Tc-99m Tilmanocept · 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.